Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masahito Onoda

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 13, 2002
[Weber-Christian disease]Kazuo Takahashi, Masahito Onoda
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 13, 2007
[Adverse effects of chemical mediator release inhibitors]Masahito Onoda, Shigeko Inokuma, Zenro Ikezawa
Rheumatology International|November 27, 2012
Anti-SS-A (Ro) antibody is positively associated with steroid-induced psychiatric events in systemic lupus erythematosus patientsMasahito Onoda, Shigeko Inokuma, Satoko Arai
Clinical and Experimental Rheumatology|June 29, 2013
Cut-off levels of salivary beta2-microglobulin and sodium differentiating patients with Sjögren's syndrome from those without it and healthy controlsHiromitsu Asashima, Shigeko Inokuma, Masahito Onoda, et al.
Acta Dermato-Venereologica|November 25, 2010
Cryptococcal cellulitis in a patient with myelodysplastic syndromeYusuke Inoue, Masahito Onoda, Michiko Aihara, et al.
The Journal of Dermatology|February 13, 2007
Safety of selective cyclooxygenase-2 inhibitors and a basic non-steroidal anti-inflammatory drug (NSAID) in Japanese patients with NSAID-induced urticaria and/or angioedema: Comparison of meloxicam, etodolac and tiaramideNaoko Inomata, Hiroyuki Osuna, Junko Yamaguchi, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 13, 2002
[Weber-Christian disease]Kazuo Takahashi, Masahito Onoda
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 13, 2007
[Adverse effects of chemical mediator release inhibitors]Masahito Onoda, Shigeko Inokuma, Zenro Ikezawa
Rheumatology International|November 27, 2012
Anti-SS-A (Ro) antibody is positively associated with steroid-induced psychiatric events in systemic lupus erythematosus patientsMasahito Onoda, Shigeko Inokuma, Satoko Arai
Clinical and Experimental Rheumatology|June 29, 2013
Cut-off levels of salivary beta2-microglobulin and sodium differentiating patients with Sjögren's syndrome from those without it and healthy controlsHiromitsu Asashima, Shigeko Inokuma, Masahito Onoda, et al.
Acta Dermato-Venereologica|November 25, 2010
Cryptococcal cellulitis in a patient with myelodysplastic syndromeYusuke Inoue, Masahito Onoda, Michiko Aihara, et al.
The Journal of Dermatology|February 13, 2007
Safety of selective cyclooxygenase-2 inhibitors and a basic non-steroidal anti-inflammatory drug (NSAID) in Japanese patients with NSAID-induced urticaria and/or angioedema: Comparison of meloxicam, etodolac and tiaramideNaoko Inomata, Hiroyuki Osuna, Junko Yamaguchi, et al.
Pageof 1